بررسی تأثیر بهزیستی درمانی بر افسردگی، اضطراب و کنترل قند خون در زنان مبتلابه دیابت نوع دو

1. Wu J, Shi S, Wang H, Wang S.. Mechanismsunderlying the effect of polysaccharides in thetreatment of type 2 diabetes: A review. CarbohydrPolym 2016;144: 474-94
2. Centers for Disease Control and Prevention (CDC). Estimatesof diabetes and its burden in the United States: National diabetes statistics report. Atlanta: Centers for Disease Control and Prevention; 2014.
3. Ingelfinger, J. R., Jarcho, J. A. Increase in the Incidence of Diabetes and Its Implications. N Engl JMed 2017; 376: 1419-29
4. Anjana RM, Deepa M, Pradeepa R, Mahanta J, Narain K, Das HK, Adhikari P, Rao PV, Saboo B, Kumar A, Bhansali A. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR–INDIAB population-based cross-sectional study. The Lancet Diabetes & Endocrinology, 2017;5(8):585-96.
5. Gholamrezaei S, Ghazanfari F, Saeidi L. The effectivess of mindfulness-BASED cognitive therapy (MBCT) on decreased eating disorder behaviors ,psychological distress and body worthiness,in type 2 dibetes patients: Journal of Diabetes and Metabolism, 2019; 18(6):19
6. American Diabetes Association. Standards of medical care in diabetes—2015 abridged for primary care providers. Clinical diabetes: a publication of the American Diabetes Association 2015; 33(2):97.
7. Allison Bickett ،Hazel Tapp. Anxiety and diabetes: Innovative approaches to management in primary care Department of Family Medicine, Carolinas HealthCare System, Charlotte, NC, 2016

.8. Young-Hyman D, De Groot M, Hill-Briggs F, Gonzalez JS, Hood K, Peyrot M. Psychosocial care for people with diabetes: a position statement of the American Diabetes Association. Diabetes Care 2016; 39(12):2126-40.

9. Allison Bickett ،Hazel Tapp: Anxiety and diabetes: Innovative approaches to management in primary care Department of Family Medicine, Carolinas HealthCare System, Charlotte, NC 28207, USAAllison Bickett. Email: Allison.bickett@carolinashealthcare.org, 2016
10. AlKhathami AD, Alamin MA, Alqahtani AM, Alsaeed WY, AlKhathami MA, Al-Dhafeeri AH. Depression and anxiety among hypertensive and diabetic primary health care patients: Could patients’ perception of their diseases control be used as a screening tool? Saudi Medical Journal. 2017; 38(6):621.
11. Al-Mohaimeed AA. Prevalence and factors associated with anxiety and depression among type 2 diabetes in Qassim, KSA: A descriptive cross-sectional study. Journal of Taibah University Medical Sciences. 2017.
12. Akushevich I, Yashkin AP, Kravchenko J, Fang F, Arbeev K, Sloan F, Yashin AI. Identifying the Causes of the Changes in the Prevalence Patterns of Diabetes in Older US Adults: A New Trend Partitioning Approach. Journal of Diabetes and its Complications 2018; 32(4):362-367.
13. Kuru, E., Safak, Y., Özdemir, İ., Tulacı, R., Özdel, K., Özkula, N., Örsel, S.. Cognitivedistortions in patients with social anxiety disorder: Comparison of a clinical group and healthy controls. The European Journal of Psychiatry, 2017
14. Mohammadi Sh, Norimah AK, Abd Talib R. Amani R. Knowledge, attitude and practices on diabetes among type 2 diabeticpatients in Iran: A cross-sectional study. Science Journal of PublicHealth. 2015; 3(4):520-4. [DOI: 10.11648/j.sjph.20150304.20]
15. Cavagnolli G, Pimentel AL, Freitas PA, Gross JL, Camargo JL. Effect of ethnicity on HbA1c levels in individuals without diabetes: Systematic review and meta-analysis. PLoS One 2017; 12(2):0171315
16. Behnam Molavi, Aidin Yaghoobi Notash, Fezeh Elyasi nia, Laleh Amirsoleimany: The role of best possible self (BPS) intervention on increasing of optimism in patients with type2 diabetes, Journal of Diabetes and Metabolism, 2019;6 (18): 6
17. Huges A.E., Berg C.A., Wiebe D. J.. Emotional processing and self–control in Adolescents with Type 1 Diabetes. Journal of Pediatric Psychology, 201437(8): 925-934.
18. Weitz E. S., Hollon S. D., Twisk J., van Straten A., Huibers M. J. H., David D., Cuijpers P.. Baseline depression severity as moderator of depression outcomes between Cognitive Behavioral Therapy vs Pharmacotherapy. JAMA Psychiatry, 2015: 1–8.

19.Fava G. A., Cosci F., Guidi J., Tomba E.. Well‐being therapy in depression: new insights into the role of psychological well‐being in the clinical process. Depression and anxiety, 2017

20.Fava G. A., Rafanelli C., Grandi S., Conti S., Belluardo P.. Prevention of recurrent depression with cognitive behavioral therapy: Preliminary findings. Archives of General Psychiatry, 1998; 55: 816-820.

21.Godecke K.. Substance and medication induced mood disorders. University of Utah Psychiatric Department. Retrieved from  https://healthcare.utah.edu/echo/docs/2017-11-9, 2015

22. Najat H. Well-bing therapy: treatment manual clinical applications: Mashhad, 2019:160

23.Beck AT, Steer RA, Brown G. TX: Psychological Corporation; 1996.

24.. Steer RA, Clark DA, Beck AT, Ranieri WF. Common and specific dimensions of self-reported anxiety and depression: the BDI-II versus the BDI-IA. Behav Res Ther. 1999;37(2):183-90. doi: 10.1016/s0005-7967(98)00087-4 pmid: 9990749

25. Fata L, Birashk B, Atefvahid0 M, Dabson K. [Meaning Assignment Structures/ Schema, Emotional States and Cognitive Processing of Emotional Information: Comparing Two Conceptual Frameworks.Iran]. J Psychiatry Clin Psychol. 2005;11(3):312- 26.
26. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psycho-metric properties. J Consult Clin Psychol. 1988; 56: 893-97.
27. Rafiee M, Seifi A. Reliability and reliability of beck anxiety scale among students. J Thought Behav. 2013; 7: 37-48.

28.Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J. Harrisons Manual of Medicine. 19th ed. McGraw-Hill Education; 2016.

29.American Diabetes Association. Standards of medical care indiabetes. Clinical and Applied Research and Education. 2017;40(Suppl. 1):S1-S2. [DOI: 10.2337/dc17-S001]

30. Nemattavousi M. Job stress and affective well-being: the mediating effects of core self-valuations. Developmental psychology (journal of iranian psychologists) 2014; 10(38): 103-121.
31. Pradhan S, Chauhan S, Samal P. Incidental detection of a rare hemoglobin variant (Hemoglobin N Seattle) leading to undetectable levels of HbA1c in a diabetic female: a case report. Thalassemia Reports, 2017
32. Anthony EG, Kritz-Silverstein D, Barrett-Connor E. Optimism and mortality in older men and women: The Rancho Bernardo Study. Journal of aging research 2016, 2016
33. Lee HW, Shin S, Bunds KS, Kim M, Cho KM. Rediscovering the positive psychology of sport participation: Happiness in a ski resort context. Applied Research in Quality of Life, 2014 1;9(3):575-90.
34. Fava G., Rafanelli C., Ottolini, F., Ruini C., Cazzaro, M., Grandi S.. Psychological Well-Being and Residual Symptoms In Remitted Patients With Panic Disorder And Agoraphobia, 2001
35. Ruini C., Belaise C., Brombin C., Caffo E, Fava G. A.. Well-being therapy in school setting: A pilot study. Psychotherapy and Psychosomatics, 2006; 75: 331- 336.
36. Fava G. A., Ruini C., Rafanelli C., Finos L., Salmaso L., Mangelli L., Et Al. Well-Being Therapy of Generalized Anxiety Disorder. Psychotherapy And Psychosomatics, 2005;74: 26-30.
37. Fava G. A., Ruini C.. Development And Characteristics of A Well-Being Enhancing Psychotherapeutic Strategy: Well-Being Therapy. Journal Of Behavior Therapy and Experimental Psychiatry, 2003; 34: 45-63.
38. Siev J., Steketee G., Fama J., Wilhelm S.. Cognitive and Clinical Characteristics of Sexual and Religious Obsessions, J Cogn Psychother, 2015; 1; 25(3): 167–176.
39. Nyer M.. Stimulant Enhancement of Well-Being Therapy for Depression, ClinicalTrials.gov Identifier, 2017; 12: 27-34.
40. Yang C., Qu Y., Abe M., Nozawa D., Chaki S., Hashimoto K.. (R)-ketamine shows greater potency and longer lasting antidepressant effects than its metabolite (2R, 6R)-hydroxynorketamine. Biological psychiatry, 2017; 82(5): 43-44.
41. Moeenizadeh M., Zarif H.. The Efficacy of Well-Being Therapy for Depression in Infertile Women. International Journal of Fertility & Sterility, 2017;10(4): 363-370

42.Nivo nordisk. A good lifewith diabetes: acoping and self help tool for people with diabetes, 2014

43. Gandaharizadeh A., Aghamohammadian S.H., Bagheri F.. The Effectiveness of Psychological Well-being Treatment on Clinical Syndrome and Positive and Negative Affections in Patients with Obsessive-Compulsive Disorder, 2018, DOI: 10.21859/ijpn-06017
44. Ramesh S., Alizadeh Moghdam A., Safari A., Feizi M.. The Relationship Between Anxiety, Depression and Strees with the Severity of Diabetes: The Role of the mediator of quality of life, 2019;18(2):19
45. Poulsen K.M., Pachana N.A., McDermott, B.M. Health professionals’ detection of depression and anxiety in their patients with diabetes: The influence of patient, illness and psychological factors. Journal of health psychology, 2016; 21(8): 1566-1575.
46. Massey C.N, Feig E.H, Duque-Serrano L, Wexler D, Moskowitz J.T, Huffman J.C.Well-being interventions for individuals with diabetes: A systematic review.Diabetes Research and Clinical Practice, 2019; 147:118-133. https://doi.org/10.1016/j.diabres.2018.11.014
47. Huffman J.C, DuBois C.M, Millstein R.A, Celano C.M, Wexler D. Positive Psychological Interventions for Patients with Type 2 Diabetes: Rationale, Theoretical Model, and Intervention Development. Hindawi Publishing, Corporation Journal of Diabetes Research, 2015. http://dx.doi.org/10.1155/2015/428349
48. DuBois C.M, Millstein R.A, Celano C.M, Wexler D.J, Huffman J.C. Feasibility and Acceptability of a Positive Psychological Intervention for Patients With Type 2 Diabetes. Prim Care Companion CNS Disord. 2016; 18(3):10. doi:10.4088/PCC.15m01902:
49. Khodabakhash R, Khosravi Z, Shahangian S. Effect of Positive Psychotherapy in Depression Symptoms and Character Strengths in Cancer Affected Patients.Positive Psychology, 2015;1(1):35-50. (persian)
50. Frazier J.P, Hilliard M, Cochrane K, Hood K.K. The Impact of Positive Psychology on Diabetes Outcomes: A Review, 2012;12(3): 1116-1124. doi:10.4236/psych.2012.312 A165
51. Abuhegzy H, Elkeshishi H, Saleh N, Sherra KH, Ismail A, Kamel A, Abd El Azim KH, Khalil D.. Longitudinal effect of depression on glycemic control in patients with type 2 diabetes: a 3-year prospective study, 2016
52. Goorden M, van der Feltz-Cornelis CM, van Steenbergen-Weijenburg KM, Horn EK, Beekman AT, Hakkaart-van Roijen L. cost-utility of collaborative care for the treatment of comorbid major depressive disorder in outpatients with chronic physical conditions. a randomized controlled trial in the general hospital setting (cc–DiM). Neuropsychiatric disease and treatment 2017; 13:1881.
53. Mantzios M. Exploring the relationship between worry and impulsivity in military recruits: The role of mindfulness and self‐compassion as potential mediators. Stress and Health 2014; 30(5):397-404
54. Creswell JD, Way BM, Eisenberger NI, Lieberman MD. Neural correlates of dispositional mindfulness during affect labeling. Psychosomatic medicine 2007; 69(6):560-5.
55. Neff KD. Self-compassion. Mindfulness in Positive Psychology: The Science of Meditation and Wellbeing 2016; 37.